Answers are grounded in this paper and cite their sources.
BACKGROUND Anthocyanin‐rich colored wheat has attracted interest as a functional food for glycemic health, but evidence from human studies remains limited. This study evaluated whether chapattis prepared from purple (‘Jamvant’), blue (‘Neel‐kanth’) and black (‘Shyam‐kanak’) wheat produced lower acute glycemic responses than those prepared from conventional white wheat (‘C‐306’) in healthy adults. RESULTS Colored wheat varieties had markedly higher anthocyanin content and antioxidant activity than ‘C‐306’. Total anthocyanin content ranged from 15.35 ± 6.27 mg kg −1 flour in ‘C‐306’ to 251.97 ± 15.07 mg kg −1 flour in ‘Shyam‐kanak’. The glycemic index (GI) was assessed in three independent randomized crossover trials at two centers using procedures based on ISO 26642:2010 principles, with 14, 14, and 13 completers. Trials 1 and 2 used 35 g available carbohydrate and Trial 3 used 50 g. Mean GI values ranged from 52 to 60 in Trial 1, 58 to 63 in Trial 2, and 71 to 74 in Trial 3. Mixed‐effects analyses showed no significant overall treatment effect, and no comparison between colored and white wheat remained significant after Holm adjustment. Inter‐individual variability was substantial. CONCLUSION Despite marked differences in anthocyanin content and antioxidant activity, colored wheat chapattis did not exhibit a consistently lower GI than white wheat chapattis. Anthocyanin biofortification alone may therefore be insufficient to modify the acute glycemic response to chapatti consumption substantially. Longer term intervention studies are warranted to determine whether anthocyanin‐rich wheat confers broader metabolic benefits involving insulin sensitivity, oxidative status, inflammation, or gut microbiota.
No takes yet. Share an insight, caveat, or question.
Sheoran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: